Calcium pyrophosphate deposition disease
CPPD disease usually affects patients 60 years and older and can have overlap with osteoarthritis. It affects women and men equally. Metabolic derangements such as hypophosphatemia, hypomagnesemia, and hypercalcemia increase the risk of CPPD. As such, conditions that predispose to metabolic derangements are associated with CPPD, such as hyperparathyroidism, hypothyroidism, Gitelman syndrome, hemochromatosis, and loop diuretic use. Similarly, inflammatory conditions of the joint can predispose to CPPD such as acute illness or joint trauma during the postoperative period, rheumatoid arthritis, and osteoarthritis.
While acute CPPD is more common and is often mistaken for gout, the less common chronic form of CPPD (<5% of cases of CPPD) can be mistaken for rheumatoid arthritis. Chronic CPPD often involves multiple joints, commonly involving the small peripheral joints of the arms and legs, often symmetrically. Inflammation can last for months but, unlike rheumatoid arthritis, inflammation of the affected joints can wax and wane independently of one another.
If the disease occurs in patients younger than 60, a familial history should be elicited as there are certain genetic associations that can cause earlier onset of disease.
The pathophysiology of pseudogout is not well understood, but CPP crystals forming in the cartilage is the first step in the disease process. Deposition of the CPP crystals affects the balance toward the production of pro-destructive prostaglandins and metalloproteinases, which destroy the chondrocytes and synoviocytes, cells that are important for the structural framework of cartilage and synovium.
E83.59 – Other disorders of calcium metabolism
239832006 – Calcium Pyrophosphate Deposition Disease
Differential Diagnosis & Pitfalls
Drug Reaction Data